80_FR_57567 80 FR 57383 - Center for Scientific Review; Notice of Closed Meetings

80 FR 57383 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 184 (September 23, 2015)

Page Range57383-57384
FR Document2015-24133

Federal Register, Volume 80 Issue 184 (Wednesday, September 23, 2015) 
[Federal Register Volume 80, Number 184 (Wednesday, September 23, 2015)]
[Notices]
[Pages 57383-57384]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-24133]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Bioengineering Sciences Biocomputational and 
Modeling.
    Date: October 28, 2015.
    Time: 2:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Joseph Thomas Peterson, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 
20892, 301-408-9694, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Cell Biology, Developmental Biology, and 
Bioengineering.
    Date: October 29-30, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Raj K. Krishnaraju, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6190, Bethesda, MD 20892, 301-
435-1047, [email protected].

    Name of Committee: Molecular, Cellular and Developmental 
Neuroscience Integrated Review Group; Cellular and Molecular Biology 
of Glia Study Section.
    Date: October 29-30, 2015.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton McLean Tysons Corner, 7920 Jones Branch Drive, 
McLean, VA 22102.
    Contact Person: Linda MacArthur, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4187, Bethesda, MD 20892, 301-
537-9986, [email protected].

    Name of Committee: Oncology 1-Basic Translational Integrated 
Review Group; Tumor Progression and Metastasis Study Section.
    Date: October 29-30, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites, DC Convention Center, 900 10 Street, 
Washington, DC 20001.
    Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301-495-
1718, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Bacterial Pathogenesis.
    Date: October 29-30, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Warwick Allerton Hotel, 701 North Michigan Avenue, 
Chicago, IL 60611.
    Contact Person: Richard G. Kostriken, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 
20892, 240-519-7808, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Biophysical, Physiological, Pharmacological and 
Bioengineering Neuroscience.
    Date: October 29-30, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Georgetown, 2350 M St. NW., Washington, DC 
20037.

[[Page 57384]]

    Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific 
Review Officer, National Institutes of Health, Center for Scientific 
Review, 6701 Rockledge Drive, Room 5211, Bethesda, MD 20892, 
[email protected].

    Name of Committee: Cell Biology Integrated Review Group; 
Cellular Mechanisms in Aging and Development Study Section.
    Date: October 29-30, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: John Burch, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, 301-408-
9519, [email protected].

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Genetics of Health and Disease Study Section.
    Date: October 29-30, 2015.
    Time: 8:30 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Contact Person: The Fairmont Washington, DC, 2401 M Street NW., 
Washington, DC 20037.
    Contact Person: Cheryl M. Corsaro, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 
20892, (301) 435-1045, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 18, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-24133 Filed 9-22-15; 08:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 184 / Wednesday, September 23, 2015 / Notices 57383 solution to this delivery problem, RNAi Collaborative Research Opportunity: Name of Committee: Center for Scientific cannot fulfill its therapeutic promise. The National Institute on Aging, Review Special Emphasis Panel; Investigators at the National Institutes Laboratory of Molecular Biology and Fellowships: Cell Biology, Developmental of Health have developed novel Biology, and Bioengineering. Immunology, is seeking statements of Date: October 29–30, 2015. compositions and methods for capability or interest from parties Time: 8:00 a.m. to 6:00 p.m. delivering inhibitory oligonucleotides to interested in collaborative research to Agenda: To review and evaluate grant cells in a targeted and efficient manner. further develop, evaluate, or applications. The compositions and methods are commercialize chemokine-based siRNA/ Place: Hyatt Regency Bethesda, One based on utilizing a cell surface receptor shRNA technology for treatment of Bethesda Metro Center, 7400 Wisconsin targeting ligand, such as cytokine or cancers and autoimmune diseases, i.e. Avenue, Bethesda, MD 20814. chemokine, and a domain that binds an to control expression of Contact Person: Raj K. Krishnaraju, Ph.D., inhibitory oligonucleotide, to efficiently immunomodulatory cytokines and other Scientific Review Officer, Center for deliver the inhibitory oligonucleotide to Scientific Review, National Institutes of factors that facilitate tumor escape, Health, 6701 Rockledge Drive, Room 6190, the cell that expresses the cell surface activity of regulatory T cells or Th2 type Bethesda, MD 20892, 301–435–1047, receptor targeting ligand. Chemokine of cells. This technology can be also kkrishna@csr.nih.gov. receptors are differentially expressed on utilized to boost vaccine responses Name of Committee: Molecular, Cellular various cells, including tumors; hence against cancers and chronic infectious and Developmental Neuroscience Integrated this technology allows targeting siRNA diseases. Please contact John D. Hewes, Review Group; Cellular and Molecular to aberrant cells. Gene silencing can also Ph.D. at 240–276–5515 or john.hewes@ Biology of Glia Study Section. be achieved in variety of immune cells nih.gov for more information. Date: October 29–30, 2015. by targeting cytokine receptors. This Time: 8:00 a.m. to 2:00 p.m. Dated: September 17, 2015. technology has great potential for Agenda: To review and evaluate grant developing into a safe and effective Richard U. Rodriguez, applications. means of delivering therapeutic siRNAs. Acting Director, Office of Technology Place: Hilton McLean Tysons Corner, 7920 Transfer, National Institutes of Health. Jones Branch Drive, McLean, VA 22102. Potential Commercial Applications [FR Doc. 2015–24137 Filed 9–22–15; 8:45 am] Contact Person: Linda MacArthur, Ph.D., • Treatment of cancers and BILLING CODE 4140–01–P Scientific Review Officer, Center for autoimmune diseases by delivery of Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4187, siRNA to tumor cells or various Bethesda, MD 20892, 301–537–9986, aberrantly functioning immune cells. DEPARTMENT OF HEALTH AND macarthurlh@csr.nih.gov. • This technology can be used to HUMAN SERVICES Name of Committee: Oncology 1-Basic boost vaccine responses against cancers Translational Integrated Review Group; and chronic infectious diseases. National Institutes of Health Tumor Progression and Metastasis Study • Targeted delivery of fluorochrome- Section. labeled RNA both in vitro and in vivo for Center for Scientific Review; Notice of Date: October 29–30, 2015. diagnostic purposes, for example, to Closed Meetings Time: 8:00 a.m. to 6:00 p.m. trace or localize various cells and to Pursuant to section 10(d) of the Agenda: To review and evaluate grant determine tumor metastasis and Federal Advisory Committee Act, as applications. aberrant proliferation or homing of Place: Embassy Suites, DC Convention amended (5 U.S.C. App.), notice is Center, 900 10 Street, Washington, DC 20001. immune cells. hereby given of the following meetings. Contact Person: Rolf Jakobi, Ph.D., Competitive Advantages The meetings will be closed to the Scientific Review Officer, Center for public in accordance with the Scientific Review, National Institutes of • Simple method for linking siRNA to provisions set forth in sections Health, 6701 Rockledge Drive, Room 6187, polypeptides to create non-covalent or 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MSC 7806, Bethesda, MD 20892, 301–495– covalent complexes as amended. The grant applications and 1718, jakobir@mail.nih.gov. • In vivo targeted delivery of the discussions could disclose Name of Committee: Center for Scientific inhibitory RNAs into cells rather than Review Special Emphasis Panel; Topics in confidential trade secrets or commercial systemically Bacterial Pathogenesis. • Delivery of multiple inhibitory property such as patentable material, and personal information concerning Date: October 29–30, 2015. RNAs to target multiple genes Time: 8:00 a.m. to 6:00 p.m. • Long-term repression of target gene individuals associated with the grant Agenda: To review and evaluate grant expression through RNAi phenomenon applications, the disclosure of which applications. would constitute a clearly unwarranted Place: The Warwick Allerton Hotel, 701 Development Stage invasion of personal privacy. North Michigan Avenue, Chicago, IL 60611. • In vitro data available Name of Committee: Center for Scientific Contact Person: Richard G. Kostriken, • In vivo data available (animal) Review Special Emphasis Panel; Member Ph.D., Scientific Review Officer, Center for • In situ data available Conflict: Bioengineering Sciences Scientific Review, National Institutes of Inventors: Bira Arya, Purevdorj Biocomputational and Modeling. Health, 6701 Rockledge Drive, Room 3192, Date: October 28, 2015. MSC 7808, Bethesda, MD 20892, 240–519– Olkhanud, Juan Espinoza (all of NIA) Time: 2:00 p.m. to 4:30 p.m. 7808, kostrikr@csr.nih.gov. Intellectual Property: HHS Reference No. E–051–2008/0— Agenda: To review and evaluate grant Name of Committee: Center for Scientific • US Patent No. 8,703,921 issued 22 applications. Review Special Emphasis Panel; Place: National Institutes of Health, 6701 Fellowships: Biophysical, Physiological, mstockstill on DSK4VPTVN1PROD with NOTICES Apr 2014 Rockledge Drive, Bethesda, MD 20892, Pharmacological and Bioengineering • US Patent Application No. 14/ (Telephone Conference Call). Neuroscience. 220,726 filed 20 Mar 2014 Contact Person: Joseph Thomas Peterson, Date: October 29–30, 2015. • Various international patents/patent Ph.D., Scientific Review Officer, Center for Time: 8:00 a.m. to 5:00 p.m. applications Scientific Review, National Institutes of Agenda: To review and evaluate grant Licensing Contact: Betty B. Tong, Health, 6701 Rockledge Drive, Room 4118, applications. Ph.D.; 301–594–6565; tongb@ MSC 7814, Bethesda, MD 20892, 301–408– Place: The Westin Georgetown, 2350 M St. mail.nih.gov 9694, petersonjt@csr.nih.gov. NW., Washington, DC 20037. VerDate Sep<11>2014 18:00 Sep 22, 2015 Jkt 235001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\23SEN1.SGM 23SEN1

57384 Federal Register / Vol. 80, No. 184 / Wednesday, September 23, 2015 / Notices Contact Person: Paula Elyse Schauwecker, have approved the Phase IV Early Federal and State agencies act as Ph.D., Scientific Review Officer, National Restoration Plan and Environmental trustees on behalf of the public to assess Institutes of Health, Center for Scientific Assessments (Phase IV ERP/EAs). The natural resource injuries and losses, and Review, 6701 Rockledge Drive, Room 5211, to determine the actions required to Trustees have selected 10 early Bethesda, MD 20892, schauweckerpe@ csr.nih.gov. restoration projects in the Phase IV ERP/ compensate the public for those injuries EAs that are consistent with the early and losses. OPA further instructs the Name of Committee: Cell Biology Integrated Review Group; Cellular restoration program alternatives selected designated trustees to develop and Mechanisms in Aging and Development in the final Phase III Early Restoration implement a plan for the restoration, Study Section. Plan/Programmatic Environmental rehabilitation, replacement, or Date: October 29–30, 2015. Impact Statement (Phase III ERP/PEIS). acquisition of the equivalent of the Time: 8:00 a.m. to 6:00 p.m. The projects selected in the Phase IV injured natural resources under their Agenda: To review and evaluate grant ERP/EAs will continue the process of trusteeship, including the loss of use applications. restoring natural resources and services and services from those resources from Place: Residence Inn Bethesda, 7335 injured or lost as a result of the the time of injury until the time of Wisconsin Avenue, Bethesda, MD 20814. Deepwater Horizon oil spill, which restoration to baseline (the resource Contact Person: John Burch, Ph.D., Scientific Review Officer, Center for occurred on or about April 20, 2010, in quality and conditions that would exist Scientific Review, National Institute of the Gulf of Mexico. The Phase IV ERP/ if the spill had not occurred) is Health, 6701 Rockledge Drive, Room 3213, EAs also retains a notice of change and complete. Pursuant to the process MSC 7808, Bethesda, MD 20892, 301–408– supporting analysis for one Phase III articulated in the Framework for Early 9519, burchjb@csr.nih.gov. Early Restoration Project, Restoration Addressing Injuries Name of Committee: Genes, Genomes, and ‘‘Enhancement of Franklin County Parks Resulting from the Deepwater Horizon Genetics Integrated Review Group; Genetics and Boat Ramps—Eastpoint Fishing Pier Oil Spill (Framework Agreement), the of Health and Disease Study Section. Improvements’’ that was included in the Trustees previously selected, and BP Date: October 29–30, 2015. Draft Phase IV plan. agreed to fund, a total of 54 early Time: 8:30 a.m. to 3:00 p.m. restoration projects, expected to cost Agenda: To review and evaluate grant ADDRESSES: Obtaining Documents: You applications. may download the Phase IV ERP/EAs at: approximately $700 million, through Contact Person: The Fairmont Washington, http://www.gulfspillrestoration.noaa.gov the Phase I Early Restoration Plan/ DC, 2401 M Street NW., Washington, DC or http://www.doi.gov/ Environmental Assessment (Phase I 20037. deepwaterhorizon. Alternatively, you ERP/EA), Phase II Early Restoration Contact Person: Cheryl M. Corsaro, Ph.D., may request a CD of the Phase IV ERP/ Plan/Environmental Review (Phase II Scientific Review Officer, Center for EAs (see FOR FURTHER INFORMATION ERP/ER), and the Programmatic and Scientific Review, National Institutes of Phase III Early Restoration Plan and CONTACT). You may also view the Health, 6701 Rockledge Drive, Room 2204, Early Restoration Programmatic MSC 7890, Bethesda, MD 20892, (301) 435– document at any of the public facilities listed at http:// Environmental Impact Statement (Phase 1045, corsaroc@csr.nih.gov. www.gulfspillrestoration.noaa.gov. III ERP/PEIS). These plans are available (Catalogue of Federal Domestic Assistance at: http:// Program Nos. 93.306, Comparative Medicine; FOR FURTHER INFORMATION CONTACT: www.gulfspillrestoration.noaa.gov/ 93.333, Clinical Research, 93.306, 93.333, Nanciann Regalado, at nanciann_ restoration/early-restoration/ 93.337, 93.393–93.396, 93.837–93.844, regalado@fws.gov. The Trustees are: 93.846–93.878, 93.892, 93.893, National SUPPLEMENTARY INFORMATION: • U.S. Department of the Interior Institutes of Health, HHS) Introduction (DOI), as represented by the National Dated: September 18, 2015. Park Service, U.S. Fish and Wildlife Anna Snouffer, On or about April 20, 2010, the Service, and Bureau of Land Deputy Director, Office of Federal Advisory mobile offshore drilling unit Deepwater Management; Committee Policy. Horizon, which was being used to drill • National Oceanic and Atmospheric [FR Doc. 2015–24133 Filed 9–22–15; 08:45 am] a well for BP Exploration and Administration (NOAA), on behalf of BILLING CODE 4140–01–P Production, Inc. (BP), in the Macondo the U.S. Department of Commerce; prospect (Mississippi Canyon 252– • U.S. Department of Agriculture MC252), experienced a significant (USDA); DEPARTMENT OF THE INTERIOR explosion, fire, and subsequent sinking • U.S. Department of Defense in the Gulf of Mexico, resulting in an (DOD); 1 [FWS–R4–FHC–2015–N160; unprecedented volume of oil and other • U.S. Environmental Protection FVHC98210408710–XXX–FF04G01000] discharges from the rig and from the Agency (USEPA); wellhead on the seabed. The Deepwater • State of Louisiana Coastal Deepwater Horizon Oil Spill; Final Horizon oil spill is the largest oil spill Protection and Restoration Authority, Phase IV Early Restoration Plan and in U.S. history, discharging millions of Oil Spill Coordinator’s Office, Environmental Assessments barrels of oil over a period of 87 days. Department of Environmental Quality, AGENCY: Interior. In addition, well over 1 million gallons Department of Wildlife and Fisheries, ACTION: Notice of availability. of dispersants were applied to the and Department of Natural Resources; waters of the spill area in an attempt to • State of Mississippi Department of SUMMARY: In accordance with the Oil disperse the spilled oil. An Environmental Quality; • State of Alabama Department of mstockstill on DSK4VPTVN1PROD with NOTICES Pollution Act of 1990 (OPA), the undetermined amount of natural gas National Environmental Policy Act was also released into the environment Conservation and Natural Resources and (NEPA), and the Framework Agreement as a result of the spill. Geological Survey of Alabama; for Early Restoration Addressing The Trustees are conducting the 1 Although a trustee under OPA by virtue of the Injuries Resulting from the Deepwater natural resource damage assessment for proximity of its facilities to the Deepwater Horizon Horizon Oil Spill, notice is hereby given the Deepwater Horizon oil spill under oil spill, DOD is not a member of the Trustee that the Federal and State natural the Oil Pollution Act 1990 (OPA; 33 Council and does not currently participate in resource trustee agencies (Trustees) U.S.C. 2701 et seq.). Pursuant to OPA, Trustee decision making. VerDate Sep<11>2014 18:00 Sep 22, 2015 Jkt 235001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\23SEN1.SGM 23SEN1


Document Created: 2015-12-15 09:45:22
Document Modified: 2015-12-15 09:45:22
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 28, 2015.
FR Citation80 FR 57383 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR